人工智能
,Artificial Intelligence,已成为一道亮丽的风景线而吸引人们的注意力。比尔·盖茨先生在谈到当下能对世界产生巨大影响的机会时推荐三个领域——人工智能、能源以及生物科学。因为人工智能可以使人们生活更有效率和具有创造力。我们药时代一直关注人工智能在医药研发领域的应用,分享过多篇文章。
今天,我们向朋友们推荐的是
人工智能助力临床试验受试者招募
,希望帮助临床试验
更加精准,成功的几率更高
。TD2和Deep 6 AI 这两家公司宣布建立合作伙伴关系,以加速肿瘤临床试验受试者招募。欢迎朋友们阅读新闻稿,了解详情!
TD2 and Deep 6 AI Announce Partnership to Accelerate Oncology Clinical Trial Recruitment
Artificial intelligence used to identify potential clinical trial participants in minutes
SCOTTSDALE, Ariz. and PASADENA, Calif. (May 31, 2017)
–
Translational Drug Development (TD2
) and
Deep 6 AI
announced today a formal agreement to work together in the fields of oncology and fibrosis to rapidly match eligible patients with appropriate clinical trials.
The partnership grants TD2—an oncology development organization—access to cutting-edge artificial intelligence provided by Deep 6 AI, a company dedicated to finding patients for clinical trials. With the ability to analyze all structured and unstructured clinical data, including physician notes and pathology and genomic reports, Deep 6 AI’s system expedites the process of matching patients with new drug trials—finding suitable participants in minutes rather than the months it takes to manually review patient records.